Post by
SPCEO1 on Dec 19, 2024 5:06pm
IONS drug was approved today as expected
This first indication of the three THTX acquired is small but an approval is an approval so that is good news. If the next two indications also get approved, the upside for THTX's sales is not something the market has factored into its equation yet. If all three indicatons are approved, the sales generated from this could about equal those of Egrifta currently betweeen now and the end of the decade. Sales likely will not start for this new approval until mid-late 2026 as THTX now has to pursue Canadian approval and reimbursement.
The next indication, which is potentially much larger, is up fro FAD approval in August 2025 and the final indication remains in phase III testing.
Comment by
palinc2000 on Dec 19, 2024 6:03pm
IONS still seems to be halted.... Did not see a PR yet
Comment by
palinc2000 on Dec 19, 2024 6:20pm
https://seekingalpha.com/news/4388789-ionis-gets-fda-approval-for-tryngolza